The COVID Project
The record
- Jurisdiction
- United States (federal); Department of Health and Human Services, Office of the Secretary
- Level
- Federal
- Authority
- Public Health Service Act s. 319F-3 (42 U.S.C. 247d-6d)
- Issued
- 2020-03-10 Mar. 10, 2020
- Effective
- 2020-02-04 (retroactive) (read as 2020-02-04)
- End
- Amended repeatedly through 2021 (pharmacist and pharmacy-technician authorizations Aug. 19 and Oct. 20, 2020); in force through 2024 (read as 2020-10-20)
- In force
- Feb. 4, 2020 to Oct. 20, 2020
- Quarters
- 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
- Limitation types
- Emergency declarationHealth care ordersOther
- Addressees
- manufacturers, distributors, program planners, qualified persons (covered persons)
- Functions reached
- IC infection control (testing, vaccination)
- RT pharmacy services
- HR credentialing (qualified persons)
- Collection
- Other federal health agencies AGY-FED-HEALTH-OTHER
Operative words
The Secretary is issuing this Declaration pursuant to section 319F-3 of the Public Health Service Act to provide liability immunity for activities related to medical countermeasures against COVID-19.... DATES: The Declaration was effective as of February 4, 2020.
Enforcement
Preempts State law to the extent it conflicts with the Declaration (42 U.S.C. 247d-6d(b)(8))
Notes
The base declaration; its later amendments authorized pharmacists, pharmacy interns and technicians to order and administer COVID-19 tests and vaccines nationwide, preempting contrary State scope-of-practice rules.
Retrieval noteAmendments (85 Fed. Reg. 21012, 35100, 52136, 79190; 86 Fed. Reg. 7872, 9516, 41977) not saved; cite by category.